CIK: 0001616628
Total reported value
$10.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 37.09% | — | +29.04% | |
| 2 | IEFA | Ishares Core Msci Eafe ETF | ETF-Other | 21.24% | +1.92% | +39.79% | |
| 3 | AGG | Ishares Core U.s. Aggregate | ETF-Other | 17.81% | +1.80% | +44.87% | |
| 4 | STIP | Ishares 0-5 Year Tips Bond E | ETF-Other | 11.17% | — | +42.35% | |
| 5 | REET | Ishares Global Reit ETF | ETF-Other | 5.89% | — | +46.33% | |
| 6 | IEMG | Ishares Core Msci Emerging | ETF-Emerging Markets | 4.87% | +0.25% | +36.59% | |
| 7 | IJR | Ishares Core S&p Small-cap E | ETF-Small Cap | 1.15% | +2.13% | +11.83% | |
| 8 | IGSB | Ishares 1-5y Inv Grade CORP | ETF-Other | 0.73% | +1.26% | -1.95% | |
| 9 | ALLKGUSD | Allakos INC | Stock-Other | 0.03% | — | — | |
| 10 | LDI | Loandepot INC -class A | Stock-Other | 0.01% | -0.09% | -28.49% | |
| 11 | FATE | Fate Therapeutics INC | Stock-Other | — | — | — |